Since the 1940s, antimicrobials have been our first line of defense in wound care. However, the very thing that has helped us fight infections is now starting to help the infections fight back. Structured communities of microorganisms, like bacteria, fungi, or yeast—called biofilms— are significantly more tolerant to antimicrobial treatments and harder to eradicate than…

Bringing an innovative new medical device to market is no easy task. In the U.S., approximately 75% of medical device start-ups fail. One of the best ways to guarantee success is the rapid and mass adoption of a company’s newest device—and the best way to guarantee that is for the device to be easy to operate…

Infections related to medical devices remain a persistent and costly challenge in modern healthcare. Despite the advancement of antimicrobial materials and design innovations, biofilm formation continues to undermine the efficacy of many devices – contributing to patient complications, prolonged hospital stays, and increased clinician workload. Biofilm formation on medical devices remains a major barrier to infection prevention.…

In regenerative medicine, small biological messengers are making a big impact. Extracellular vesicles (EVs) and a subset of EVs, exosomes, are transforming how scientists think about tissue repair, wound healing, and even skin rejuvenation. These nanoscale carriers of bioactive molecules – proteins, lipids, and nucleic acids – are enabling new cell-free therapies by orchestrating tissue…